tracking
Rate this Video

PE0139, PB1023 Study Results from PhaseBio

Jim Ballance, PhD, and Poul Strange, MD, PhD, of PhaseBio Pharmaceuticals discuss two different studies on PE0139 presented at the American Diabetes Association 2015 meeting in Boston.
Link
Embed
Email
Comments (0)
Add your comment
Advertisement